Patent · US Active

Peptides derived from the propeptide NTSR3 and their use in the treatment of depression

US11220527B2 · kind B2 · utility

0Cited by

5References

4Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
Université de Nice Sophia-Antipolis · FR

Inventors

Jean Mazella · Biot, FR
Marc Borsotto · Grasse, FR
Catherine Louise Heurteaux · Villeneuve-Loubet, FR
Alaeddine Djillani · Setif, DZ
Sébastien Moreno · Vence, FR
Mariel Pietri · Ajaccio, FR

Key dates

Filing date	Oct 11, 2017
Grant date	Jan 11, 2022
Priority date	—
Expiry date	Nov 4, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are new peptides derived from the neurotensin receptor 3 (NTSR3), and to their use, particularly in the treatment of various diseases, especially depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.